je.st
news
Zydus Explores Newer Treatment Options With Its Breakthrough Drug, Lipaglyn
2014-06-04 12:25:12| drugdiscoveryonline Home Page
Exploring newer therapeutic usage of its breakthrough drug Lipaglyn™ (Saroglitazar), the Zydus Group has now initiated Phase III trials of the molecule for patients suffering from lipodystrophy
Tags: options
treatment
drug
newer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||